Merck's CEO Doesn't Think That Valuations In The Biotech Industry Are 'Rich'
December 08, 2014 at 12:46 PM EST
Merck & Co., Inc. (NYSE: MRK)announced that it has agreed to acquire Cubist Pharmaceuticals Inc (NASDAQ: CBST) for $9.5 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.